Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Herzog

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Gynecologic Oncology|September 18, 2003
New approaches for the management of cervical cancerThomas J Herzog
The Oncologist|September 27, 2002
Update on the role of topotecan in the treatment of recurrent ovarian cancerThomas J Herzog
Current Oncology Reports|October 17, 2006
The current treatment of recurrent ovarian cancerThomas J Herzog
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in ovarian cancer from the European Society for Medical Oncology Virtual Congress 2020: commentaryThomas J Herzog
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Recurrent ovarian cancer: how important is it to treat to disease progression?Thomas J Herzog
Annals of Surgical Oncology|July 27, 2012
The role of heated intraperitoneal chemotherapy (HIPEC) in ovarian cancer: hope or hoax?Thomas J Herzog
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
Maintenance therapy with PARP inhibition in ovarian cancerThomas J Herzog
Gynecologic Oncology|September 18, 2003
Clinical experience with topotecan in relapsed ovarian cancerThomas J Herzog
Gynecologic Oncology|January 31, 2004
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?Thomas J Herzog
Gynecologic Oncology|December 5, 2006
Assessing the adequacy of surgical staging for ovarian cancerThomas J Herzog
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Gynecologic Oncology|September 18, 2003
New approaches for the management of cervical cancerThomas J Herzog
The Oncologist|September 27, 2002
Update on the role of topotecan in the treatment of recurrent ovarian cancerThomas J Herzog
Current Oncology Reports|October 17, 2006
The current treatment of recurrent ovarian cancerThomas J Herzog
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in ovarian cancer from the European Society for Medical Oncology Virtual Congress 2020: commentaryThomas J Herzog
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Recurrent ovarian cancer: how important is it to treat to disease progression?Thomas J Herzog
Annals of Surgical Oncology|July 27, 2012
The role of heated intraperitoneal chemotherapy (HIPEC) in ovarian cancer: hope or hoax?Thomas J Herzog
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
Maintenance therapy with PARP inhibition in ovarian cancerThomas J Herzog
Gynecologic Oncology|September 18, 2003
Clinical experience with topotecan in relapsed ovarian cancerThomas J Herzog
Gynecologic Oncology|January 31, 2004
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?Thomas J Herzog
Gynecologic Oncology|December 5, 2006
Assessing the adequacy of surgical staging for ovarian cancerThomas J Herzog
Pageof 30